About Journal
BioImpacts ISSN: 2228-5652 ; eISSN: 2228-5660
Where biological impacts are presented for biomedical and pharmaceutical scientists - Integrative Researches for Translational Medicines.
The BioImpacts (BI), which was founded by Prof. Y. Omidi in 2011, publishes timely, peer-reviewed papers on current topics important to biomedical/pharmaceutical scientists/researchers. BI papers cover a wide range of topics, including contemporary issues in biological (in vitro and in vivo) impacts of advanced and futuristic intervention at molecular, cellular, and in vivo dimensions.
Journal at a Glance
Article Sharing & Archiving Policy
This journal is published as Platinum Open Access. In accordance with the CC BY-NC license, all published articles are immediately available to everyone and their sharing, distribution and reproduction in any medium for non-commercial purposes are permitted, provided the original work is properly cited. Furthermore, all published articles are permanently archived in international repositories such as PubMed Central and DOAJ.
Article Types
Editorial; Reviews; Original research; Short Communication; Spotlight; Perspective; Commentary; Scientific Analysis, Letter; Research Education
Readership
The journal's insights make it an attractive platform for professional multidisciplinary scientists such as cellular and molecular biologists, pharmacologists, biomedical technologist, pharmaceutical scientists, biological chemists, experimental biologists, geneticists, neuroscientists, biochemists, physiologists, biomedical researchers, translational scientists, and related clinicians.